Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

Conditions

• Colon Adenocarcinoma

Interventions

• DRUG: Tolecizumab (PCSK9 Inhibitor)
• DRUG: Sintilimab

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Collaborators

• [object Object]
• [object Object]